In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Danaher takes over Beckman Coulter in deal worth $6.8bn

Executive Summary

In its latest deal that adds more instrumentation offerings, Danaher Corp. (testing and analytical systems, dental technologies, and diagnostics) is acquiring public biomedical testing company Beckman Coulter Inc. for $83.50 per share (a 47% premium to the ten-day average prior to December 9, 2010, when the takeover was rumored). Including Beckman’s 70.9mm shares outstanding, plus the assumption of debt and net cash, the transaction is valued at $6.8bn.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • Research, Analytical Equipment & Supplies
  • Services
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Hematology, Coagulation
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Cash

Related Companies